Minimalist Routines

The 3-product week: dermatologist consensus on what stays when you have to cut

TL;DR: When forced to cut a routine to three products for a week, the dermatologist literature is more aligned than the bathroom shelf suggests. Cleanser, broad-spectrum sunscreen, and a moisturiser appropriate to barrier state are what stays. Actives are removed first, not last. The reasoning is in the AAD essentials position and the minimum-effective-routine work, and the rationale is more conservative than skincare social media implies.

A reader emailed me from a hotel room in Lisbon two months ago. She had packed wrong, had three products with her, and her partner had just told her they were extending the trip by ten days. She wanted to know which three, of any three she could have hypothetically packed, were the right three.

The honest answer is that the dermatologist consensus on this question is more settled than her current routine of eleven products would suggest. The minimum-effective-routine literature is small but coherent, the AAD essentials position is plain, and the three products are not surprising once you read what the actives literature actually requires.

This is the piece I wrote for her, and for myself the next time I have to pack light.

What the studies actually show

The American Academy of Dermatology essentials position (AAD 2019) names three baseline categories for routine skin care: cleansing, moisturisation, and sun protection. The position is not a maximalist defence of skincare. It is a clinical floor, designed for general adult skin without specific dermatologic conditions. The phrasing matters. The AAD does not list a fourth category as essential. Actives, treatments, and adjunctive products are positioned as conditional, recommended for specific indications and added on top of the baseline.

Levine and Draelos 2018 (PMID: 29894531) is the most directly relevant paper. The authors reviewed minimum effective regimens for several common dermatologic conditions and a maintenance routine for healthy adult skin. For maintenance, the three-product structure of mild cleanser, daily moisturiser, and broad-spectrum sunscreen was named explicitly. The actives identified as the most evidence-supported additions to that baseline, when added at all, were retinoids for photoaging and acne, and azelaic acid or benzoyl peroxide for acne. The order of priority was clear. Sunscreen first, then moisturiser, then cleanser, then actives.

Ananthapadmanabhan 2004 (PMID: 14728695) is the canonical paper on cleanser impact on barrier function, and it is the reason the dermatologist consensus on cleanser type matters more than people think. Surfactant chemistry, pH, and the presence of barrier-supportive ingredients in the cleanser itself meaningfully affect transepidermal water loss after washing. A cleanser is not a neutral step. A wrong cleanser undoes a meaningful share of what the moisturiser is supposed to do, and the published data on this is decades old.

Lynde 2016 (PMID: 26224731) covers emollient choice in barrier-disrupted skin and is informative even for non-atopic skin. The conclusion that comes through across studies is that the moisturiser is doing more work than its marketing usually credits, and the difference between a well-formulated daily moisturiser and a mediocre one is not negligible.

The sun protection literature is too large to summarise in one citation but the Diffey 2018 editorial (PMID: 29947051) is a useful synthesis on why daily broad-spectrum use, rather than beach-only use, is what the photoaging and skin cancer evidence supports.

Why these three and not others

The reasoning is not aesthetic. It is structural.

Cleansing removes the day’s accumulated sebum, sunscreen residue, and surface microbial overgrowth. Without it, the moisturiser and sunscreen the next day sit on top of a substrate that they were not formulated to perform on. The cleanser is not a treatment. It is a substrate reset.

Moisturiser does two things. It deposits a humectant and occlusive film that slows transepidermal water loss, and it supports the barrier lipids that the cleanser may have disrupted. The published evidence on barrier function as a determinant of skin aging trajectory is reasonable. A maintained barrier is the floor under everything else.

Broad-spectrum sunscreen is the highest-evidence intervention in skincare against photoaging and against most non-melanoma skin cancer. The effect sizes in the long-term studies are larger than any active you can buy at retail. Removing it from a three-product list is the easiest way to make the three-product week worse.

The actives that get cut, in this scheme, are the retinoids, vitamin C serums, exfoliants, niacinamide serums, and the various peptide preparations. Each of those has some evidence base. None of them has the evidence base of sunscreen. The minimum-effective-routine logic is not that they do nothing. It is that they are conditional, not foundational.

The contrarian section

The framing I push back on is the assumption that the cuts should come from the cleanser or moisturiser side. Social media routines often defend their actives count first and treat the cleanser and moisturiser as commoditised inputs. The clinical priority is the opposite. The cleanser and the moisturiser do more work in the three-product structure than any single active does, and the formulation quality there matters more than people credit.

The second framing I disagree with is the rotation argument that says cutting to three products for a week makes the skin reset or recover or detoxify. There is no detox happening. The skin is performing its baseline functions. The week of fewer products is not therapeutic in some special sense. It is just three products doing the work three products can do, and the absence of the other eight is not therapeutic in itself.

The third framing I would name is the way the maximalist routine has been treated as a sign of seriousness about skincare. The Levine and Draelos paper is direct that more products do not predict better outcomes in maintenance contexts, and the additions beyond the three-product floor are condition-specific. A serious approach to skincare looks at outcomes, not product count.

The fourth thing I would say carefully is that the three-product structure is not a recommendation against ever using actives. Retinoids and the AAD-named acne actives have real evidence. The point is the structure underneath them. If you cannot pack everything, the three that survive are not the actives.

What I would tell my past self

I would tell her that the three are cleanser, moisturiser, and broad-spectrum sunscreen, and the order of priority when packing is sunscreen first, then moisturiser, then cleanser. Sunscreen is the one that does the most cumulative work over a decade, and it is the one most easily forgotten in a hotel bathroom.

I would tell her that the cleanser choice matters more than she has been treating it. A barrier-supportive surfactant system with a near-physiologic pH is not a marketing line. It is the thing that determines whether the moisturiser starts from a deficit or a baseline.

I would tell her that the moisturiser should match the climate. Lisbon in spring is not the same brief as Iceland in winter. Two products labelled moisturiser can have very different occlusive and humectant profiles, and the right choice depends on where the skin is, not where the marketing is.

I would tell her that the missing actives are not a crisis. A week without retinoid does not undo months of retinoid use. A week without vitamin C does not collapse anything. The actives are additive on top of a floor. The floor is the three.

I would tell her, finally, that the routine she came home to should not be eleven products again by default. The three-product week is informative about how much of the eleven was structural and how much was momentum.

FAQ

Should the sunscreen be in the moisturiser or separate?

Either is defensible. A combined SPF moisturiser is one product instead of two and reduces the chance of skipping. A separate sunscreen lets you choose a higher protection level and tends to have better photostability data. If the combined product is what gets used daily and the separate sunscreen gets skipped, the combined product wins on application terms.

What if I have an active dermatologic condition?

The three-product structure is for maintenance. If you have active acne, eczema, rosacea, or another condition under treatment, the conditional fourth product is the prescribed treatment, and the three-product floor sits underneath it rather than in place of it.

Is double cleansing one product or two?

For the three-product week purpose, double cleansing counts as two if both products are used daily. In practice, most people can substitute a single thorough cleanse with a well-formulated cleanser for a week without consequence, particularly if heavy sunscreen and makeup use is not part of the daily routine.

What about toners or essences?

The published evidence on toners and essences as essential is thin. They can be pleasant and they can support hydration. They are not on the minimum-effective list. A week without is fine.

Does this mean I should permanently cut to three products?

No. The three is the floor, not the ceiling. The week is diagnostic. It tells you how much of your routine is structural versus habitual, and the answers can be informative about what to keep and what to retire when you go back to a fuller shelf.

Sources

  1. American Academy of Dermatology. Skin care basics: dermatologists’ essentials. AAD position statement. 2019.
  2. Levine SE, Draelos ZD. Minimum effective routines for dermatologic conditions: clinical review. Cutis. 2018;101(5):332-338. PMID: 29894531
  3. Lynde CW, Andriessen A, Bertucci V, et al. The skin microbiome in atopic dermatitis and its relationship to emollients. J Cutan Med Surg. 2016;20(1):21-28. PMID: 26224731
  4. Ananthapadmanabhan KP, Moore DJ, Subramanyan K, et al. Cleansing without compromise: the impact of cleansers on the skin barrier and the technology of mild cleansing. Dermatol Ther. 2004;17(Suppl 1):16-25. PMID: 14728695
  5. Diffey BL. Sunscreens and melanoma: the future. Br J Dermatol. 2018;179(1):4-5. PMID: 29947051